SCHULER JACK W - 20 May 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Signature
/s/ David Patience, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
20 May 2024
Net transactions value
$0
Form type
4
Filing time
22 May 2024, 19:03:33 UTC
Previous filing
09 Apr 2024
Next filing
23 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Award +1,560,694 +22% 8,510,388 20 May 2024 By Jack W. Schuler Living Trust F1, F2
holding AXDX Common Stock 7,594 20 May 2024 Direct
holding AXDX Common Stock 5,497 20 May 2024 By Spouse F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Common Stock Warrants (right to buy) Award +1,560,694 +135% 2,716,763 20 May 2024 Common Stock 1,560,694 $1.65 By Jack W. Schuler Living Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 1,560,694 units of the issuer (the "Units") purchased by the reporting person for $1.73 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.
F2 The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.